Pintas & Mullins Law Firm

Blog Posts in November, 2015

  • Heart Devices Recalled for Safety Risks

    Over the last month the FDA has issued several warnings and recalls for heart devices, ranging from IVC filters to rotablator systems to intravascular devices. These recalls are not new: in the past five years, manufacturers have announced dozens of recalls for serious safety issues due to patient injuries and deaths. Our team of dangerous medical device lawyers highlights the most recent recalls ...
    Continue Reading
  • Staying Safe During Holiday Travel

    With Thanksgiving, Black Friday, and every event in between, millions of Americans are traveling this weekend. No matter your destination, the team at Pintas & Mullins Law Firm hopes you have a festive, happy and safe holiday weekend. Car Safety If you haven’t already, now is the time to prep your car for winter travel. Here are a few tips to help ensure you are traveling safely: Prepare a road ...
    Continue Reading
  • FDA Strengthens Invokana and Invokamet Warnings

    The FDA recently added new warnings to the type 2 diabetes drugs Invokana and Invokamet, citing the increased risk of bone fractures. This comes only about six months after the FDA warned about a dangerous blood problem called diabetic ketoacidosis , which can be fatal. Our team of Invokana lawyers is currently accepting claims related to diabetic ketoacidosis and kidney damage from this drug. The ...
    Continue Reading
  • American Mothers Twice More Likely to Die During Pregnancy Than Canadian Mothers

    A global survey of maternal mortality recently found that women in the U.S. are two times more likely to die from pregnancy- or childbirth-related causes than women in Canada. The medical malpractice attorneys at Pintas & Mullins Law Firm detail this survey and the factors driving these alarming statistics. The survey was published by the United Nations and World Bank and led by the World Health ...
    Continue Reading
  • New Lung Cancer Drug Wins Early Approval, Reports Sky-High Cost

    In an unusual move, the FDA recently announced its approval of a lung cancer drug, Tagrisso, under its fast-track program. The drug treats a specific type of lung cancer categorized by a genetic mutation that causes tumors to resist traditional therapies. Lung cancer lawyers at Pintas & Mullins Law Firm discuss this new drug, the patients eligible to receive it, and it’s astronomically high cost ...
    Continue Reading
  • Supreme Court Justice Speaks out Against Police Violence

    The U.S. Supreme Court recently ruled in favor of a police officer who shot and killed a fugitive in a high-speed chase. In the dissent, Justice Sonia Sotomayor condemns our culture of police brutality, which not only allowed the officer to be reckless in his actions but ultimately granted him immunity. Our police brutality lawyers highlight Justice Sotomayor's dissent and discuss the merits of ...
    Continue Reading
  • Supreme Court to Hear Case on Auto Accident Medical Bill Payments

    On Monday, November 9 th , 2015, the U.S. Supreme Court heard oral arguments in an important case regarding outstanding medical bills for a man injured in an auto accident. At issue is whether or not the injured man has to pay back his insurance company for his medical bills, even after his lawsuit has settled. Our team of auto accident attorneys details this case and its potentially far-reaching ...
    Continue Reading
  • New Cholesterol-Lowering Drugs Approved, But Are They Safe

    For decades, statins like Lipitor and Crestor were the first line of treatment to help regulate cholesterol levels. Two drugs in a new class of cholesterol medicines called PCSK9 inhibitors were recently approved by the FDA. As we saw with statins causing type 2 diabetes, drugs meant to benefit patients in one way often end up harming them in a completely different way. The question facing ...
    Continue Reading
  • Medication Errors During Surgery More Common Than You Think

    A new study found that medication errors occur in about half of all surgeries, and a third of these errors result in harm to patients or other adverse events. Even more troubling is that this study was conducted at Massachusetts General Hospital, a national leader in safety and Harvard affiliate. Our medical malpractice attorneys detail this study and the devastating consequences of medication ...
    Continue Reading
  • Lung Cancer Immunotherapy Drugs in Development

    The lung cancer lawyers at Pintas & Mullins Law Firm strive to keep our clients and blog up-to-date on the latest cancer research, treatments and development. We have written extensively on immunotherapy, the new and promising class of cancer treatments, and we are happy to report on several drugs being developed for lung cancer. Big Pharma companies Pfizer and Merck KGaA recently started the ...
    Continue Reading
Page 1 of 1
Free Consultation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your email.
    This isn't a valid email address.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please make a selection.
  • Please make a selection.
  • Please enter your message.